Roubaix Capital, LLC Chembio Diagnostics, Inc. Transaction History

Roubaix Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 15, 2020	SELL	$2.36 - $5.6 $459,850 - $1.09 Million	-194,852 Closed	0 $0
Q4 2019 Jan 15, 2020	SELL	$3.94 - $5.76 $269,161 - $393,494	-68,315 Reduced 25.96%	194,852 $889,000
Q3 2019 Oct 08, 2019	BUY	$4.84 - $7.25 $487,228 - $729,835	100,667 Added 61.95%	263,167 $1.61 Million
Q2 2019 Jul 30, 2019	BUY	$5.56 - $7.85 $903,499 - $1.28 Million	162,500 New	162,500 $990,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Roubaix Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Roubaix Capital, LLC with notifications on news.